Advances in the diagnosis and management of dyslipidaemia

Tackling the early stages of dyslipidaemia can help in the reduction of the risk of CVD. Our drug review outlines primary and secondary prevention measures and the need for patient-centred care which includes individual assessment of overall cardiovascular risk, followed by an analysis of the prescription data

Advances in the diagnosis and management of dyslipidaemia

Add yours ↓
Web design and marketing agency Leamington Spa